Moderna Stock Surges Following Strategic Patent Settlement That Secures Future Vaccine Revenue
Investors flocked back to Moderna on Thursday as the biotechnology giant announced a pivotal resolution to a long-standing patent dispute that had
by 
Josh Weiner
Josh Weiner